These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9193808)

  • 1. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma.
    Salvatori M; Saletnich I; Rufini V; Troncone L
    Clin Nucl Med; 1997 Jun; 22(6):380-4. PubMed ID: 9193808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel case of false-positive I-131 whole-body scan in thyroid carcinoma caused by subdural hematoma.
    Ong SC; Eng DN; Sundram FX; Chan LL
    Clin Nucl Med; 2004 Mar; 29(3):164-6. PubMed ID: 15162985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases.
    Mello ME; Flamini RC; Corbo R; Mamede M
    Arq Bras Endocrinol Metabol; 2009 Oct; 53(7):874-9. PubMed ID: 19942990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
    Abhyankar A; Basu S
    J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [False positive scintigraphic images in the surveillance of differentiated thyroid cancers].
    Rudoni S; Toubeau M; Mansuy S; Vaillant G; Verges B; Brun JM; Brunotte F
    Ann Endocrinol (Paris); 1997; 58(5):399-407. PubMed ID: 9685998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual patterns of I-131 contamination.
    Ozguven M; Ilgan S; Arslan N; Karacalioglu AO; Yuksel D; Dundar S
    Ann Nucl Med; 2004 May; 18(3):271-4. PubMed ID: 15233290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
    Khan S; Dunn J; Strickland N; Al-Nahhas A
    Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma.
    Matheja P; Lerch H; Schmid KW; Kuwert T; Schober O
    J Nucl Med; 1997 Jul; 38(7):1022-4. PubMed ID: 9225783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
    Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
    Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
    Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
    Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine.
    Sisson JC; Dewaraja YK; Wizauer EJ; Giordano TJ; Avram AM
    Thyroid; 2009 Mar; 19(3):297-303. PubMed ID: 19207003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
    Schmidt M; Dietlein M; Schröder U; Schicha H
    Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactive pulmonary tuberculosis mimicking metastasis from papillary thyroid carcinoma in diagnostic radioiodine whole-body scintigraphy.
    Picolos MK; Habra M; Safdar A; Sarlis NJ
    Thyroid; 2005 Sep; 15(9):1105-6. PubMed ID: 16187924
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.